Anna Frostegård

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2015;35(1):197-205

Induction of dendritic cell-mediated T-cell activation by modified but not native low-density lipoprotein in humans and inhibition by annexin a5: involvement of heat shock proteins.

Liu A; Ming JY; Fiskesund R; Ninio E; Karabina S-A; Bergmark C; Frostegård AG; Frostegård J
Article: ATHEROSCLEROSIS. 2014;235(2):592-598

Oxidized but not native cardiolipin has pro-inflammatory effects, which are inhibited by Annexin A5.

Wan M; Hua X; Su J; Thiagarajan D; Frostegård AG; Haeggström JZ; Frostegård J
Article: PLOS ONE. 2014;9(9):e106584

IgM-antibodies against phosphorylcholine in mothers and normal or low birth weight term newborn infants.

Frostegård AG; Sjöberg BG; Frostegård J; Norman M
Article: PLOS ONE. 2014;9(12):e111764

Antibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development.

Frostegård AG; Su J; Hua X; Vikström M; de Faire U; Frostegård J
Article: JOURNAL OF RHEUMATOLOGY. 2013;40(11):1856-1864

Low levels of antibodies against oxidized but not nonoxidized cardiolipin and phosphatidylserine are associated with atherosclerotic plaques in systemic lupus erythematosus.

Su J; Frostegård AG; Hua X; Gustafsson T; Jogestrand T; Hafström I; Frostegård J
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2013;174(3):441-448

Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality.

Frostegård AG; Hua X; Su J; Carrero JJ; Heimbürger O; Bárány P; Stenvinkel P; Frostegård J
Article: PROSTAGLANDINS & OTHER LIPID MEDIATORS. 2013;106:72-78

Annexin A5 inhibits atherogenic and pro-inflammatory effects of lysophosphatidylcholine.

Domeij H; Hua X; Su J; Bäcklund A; Yan Z; Frostegård AG; Haeggström JZ; Modéer T; Frostegård J
Article: JOURNAL OF AUTOIMMUNITY. 2010;34(2):73-79

Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism.

de Faire U; Su J; Hua X; Frostegård A; Halldin M; Hellenius M-L; Wikström M; Dahlbom I; Grönlund H; Frostegård J
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2010;39(1):77-83

Effects of anti-cardiolipin antibodies and IVIg on annexin A5 binding to endothelial cells: implications for cardiovascular disease.

Frostegård AG; Su J; von Landenberg P; Frostegård J
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2008;37(5):352-359

Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus.

Svenungsson E; Cederholm A; Jensen-Urstad K; Fei G-Z; de Faire U; Frostegård J
Article: RHEUMATOLOGY. 2008;47(8):1144-1150

Natural antibodies against phosphorylcholine as potential protective factors in SLE.

Su J; Hua X; Concha H; Svenungsson E; Cederholm A; Frostegård J
Article: DRUG NEWS AND PERSPECTIVES. 2007;20(5):321-326

Annexin A5 multitasking: a potentially novel antiatherothrombotic agent?

Cederholm A; Frostegård J
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2005;25(1):198-203

Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus.

Cederholm A; Svenungsson E; Jensen-Urstad K; Trollmo C; Ulfgren A-K; Swedenborg J; Fei G-Z; Frostegård J
Article: ARTHRITIS & RHEUMATOLOGY. 2004;50(9):2869-2876

Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus.

Cederholm A; Svenungsson E; Stengel D; Fei G-Z; Pockley AG; Ninio E; Frostegård J

Alla övriga publikationer

Published paper: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 2007;1108:96-103

Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population.

Cederholm A; Frostegård J
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2006;7(3):29

Decreased annexin A5 binding to endothelium is associated with cardiovascular disease in systemic lupus erythematosus and inhibited by IVIG

Cederholm A; Von Landenberg P; Frostegard J
Published paper: IMMUNOBIOLOGY. 2005;210(10):761-768

Annexin A5 in cardiovascular disease and systemic lupus erythematosus.

Cederholm A; Frostegård J

Anställningar

Anknuten till Forskning, Institutet för miljömedicin, Karolinska Institutet, 2024-2025
Anknuten till Forskning, Institutet för miljömedicin, Karolinska Institutet, 2021-2024

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för medicin, Huddinge, Karolinska Institutet, 2006

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI